Redmile Group LLC 13D and 13G filings for Nurix Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 9:00 pm Purchase |
2024-09-30 | 13G | Nurix Therapeutics, Inc. NRIX |
Redmile Group LLC | 6,970,307 9.900% |
1,948,421 (+38.80%) |
Filing |
| 2024-02-14 4:26 pm Purchase |
2023-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
Redmile Group LLC | 5,021,886 9.900% |
122,114 (+2.49%) |
Filing |
| 2023-02-14 4:21 pm Purchase |
2022-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
Redmile Group LLC | 4,899,772 9.900% |
1,941,488 (+65.63%) |
Filing |
| 2022-02-14 5:07 pm Purchase |
2021-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
Redmile Group LLC | 2,958,284 6.600% |
112,159 (+3.94%) |
Filing |
| 2021-02-16 4:11 pm Purchase |
2020-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
Redmile Group LLC | 2,846,125 7.300% |
2,846,125 (New Position) |
Filing |